Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
James Cheek Insider Profile
4 Followers
James Cheek, Chief Executive Officer at Genedrive, holds ― shares in Genedrive (Ticker: GB:GDR). Most recently, James Cheek Bought 666,666p shares of Genedrive on May 10, 2024 for an estimated value of 10.00K.
James Cheek has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
James Cheek does not currently own shares as a corporate insider.
A breakdown of James Cheek's holdings
Insider Roles
Chief Executive Officer
Roles that James Cheek holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by James Cheek
James Cheek's Trading History
List of latest transactions for each holding click on a transaction to see James Cheek's performance on stock
You May Also Like
James Cheek insider profile FAQ
What is the percentage of profitable transactions made by James Cheek?
The percentage of profitable transactions made by James Cheek is ―.
What is the average return per transaction made by James Cheek?
The average return per transaction made by James Cheek is ―.
What stocks does James Cheek hold?
James Cheek holds: GB:GDR stocks.
What was James Cheek’s latest transaction?
James Cheek latest transaction was an Informative Buy of 10.00K.
What was James Cheek's most profitable transaction?
James Cheek’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is James Cheek's role in Genedrive?
James Cheek's role in Genedrive is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.